An Intratracheal Instillation Bioassay System for Detection of Lung Toxicity
          Due to Fine Particles in F344 Rats by Yokohira, Masanao et al.
J Toxicol Pathol 2009; 22: 1–10
Review
An Intratracheal Instillation Bioassay System for Detection 
of Lung Toxicity Due to Fine Particles in F344 Rats
Masanao Yokohira1, Toshiya Kuno1, Keiko Yamakawa1, Nozomi Hashimoto1, 
Fumiko Ninomiya1, Satoshi Suzuki1, Kousuke Saoo1, and Katsumi Imaida1
1Onco-Pathology, Department of Pathology and Host-Defense, Faculty of Medicine, Kagawa University, 1750–1 
Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan
Abstract:  It is an urgent priority to establish in vivo bioassays for detection of hazards related to fine particles, which
can be inhaled into deep lung tissue by humans.  In order to establish an appropriate bioassay for detection of lung
damage after particle inhalation, several experiments were performed in rats using quartz as a typical lung toxic particle.
The results of pilot experiments suggest that Days 1 and 28 after intratracheal instillation of 2 mg of fine test particles
in vehicle are most appropriate for detection of acute and subacute inflammatory changes, respectively.  Furthermore,
the BrdU incorporation on Day 1 and the iNOS level on Day 28 proved to be suitable end-point markers for this purpose.
An examination of the toxicity of a series of particles was performed with the developed bioassay.  Although some
materials, including nanoparticles, demonstrated toxicity that was too strong for sensitive assessment, a ranking order
could be clarified.  The bioassay thus appears suitable for rapid hazard identification with a possible ranking of the
toxicity of various particles at single concentrations.   (J Toxicol Pathol 2009; 22: 1–10)
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Introduction
There are many toxicants in our environment, including
air pollutants.  Human investigations focusing on
concentrated ambient particles have shown acute lung
inflammation and changes in both blood indices and heart
rate1.  It is an urgent priority to establish in vivo bioassays for
the detection of hazards related to fine particles, which can
be inhaled into deep lung tissue by humans.
In quartz dust-exposed construction workers,
obstructive and restrictive loss of lung function has been
detected2, as has chronic obstructive pulmonary disease
(COPD)3,4.  These are associated with inflammatory cell
responses characterized by alveolitis with recruitment of
inflammatory cells, particularly neutrophils, and may result
in pulmonary fibrosis and impaired lung function5.
Intratracheal instillation (i.t.) of quartz into rats produces an
inflammatory reaction followed by histological changes
characteristic of lung fibrosis6, similar to the above noted
human conditions.  Borm et al. reported a no observed
adverse effect level (NOAEL) for quartz of between 0.03
and 0.13 mg/m3 (40 year exposure)7 based on an autopsy
study for humans showing that lung burdens between 0.7 and
1.7 g of quartz are associated with macules only and not
simple coal worker’s pneumoconiosis8.
In order to establish an appropriate bioassay for
detection of lung damage after particle inhalation, several
experiments were performed in rats using quartz as a typical
particle lung toxicant.  Each lung lobe was examined
histopathologically and immunohistochemically.
Histopathologically, neutrophil infiltration in the walls and in
the spaces of alveoli, pulmonary edema, pulmonary fibrosis,
macrophage infiltration in the alveoli, restructuring of walls
of the alveoli and granuloma production were all assessed
(Fig. 1).  These parameters of inflammatory change were
scored as follows: 0, no change; 1, weak; 2, moderate; and 3,
severe.  For objective assessment, 5-bromo-2’-deoxyuridine
(BrdU) incorporation and expression of inducible NO
synthase (iNOS) were also immunohistochemically
examined (Fig. 2).  Antibodies specific for BrdU provide a
sensitive method for detecting DNA replication for DNA
repair and cell proliferation in situ9, while iNOS is associated
with development of lung damage, inflammation,
granulomas and fibrosis induced by inhalation of silica10.
These markers are generally associated with inflammation
and may increase at different times after particle inhalation.
In this review, we summarize some pilot data from a
sequential analysis study, a dose response study and a
vehicle assessment study conducted to establish a bioassay
Received: 21 August 2008, Accepted: 4 November 2008
Mailing address: Katsumi Imaida, Onco-Pathology, Department of 
Pathology and Host-Defense, Faculty of Medicine, Kagawa University, 
1750–1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan
TEL: 81-87-891-2111  FAX: 81-87-891-2112
E-mail: imaida@med.kagawa-u.ac.jp2 Bioassay of Fine Particle Toxicity
Fig. 1. Histopathologic observation of lung tissue from F344 rats
treated with 4 mg/rat quartz i.t. on Day 28.  Arrows in the
figures indicate typical findings.  A, neutrophil infiltration
in the walls; B, neutrophil infiltration in the spaces of
alveoli; C, pulmonary edema; D, pulmonary fibrosis; E,
histiocytic macrophage infiltration; F, restructuring of
walls; G, granuloma.Yokohira, Kuno, Yamakawa et al. 3
model featuring instilled quartz as the positive control.
Finally, the toxicity of a series of different particle types,
including nanoparticles and diesel exhaust particles, was
also tested with our new bioassay.
Sequential Analysis Study
In order to establish an appropriate bioassay for
detection of lung damage after fine particle inhalation,
sequential histopathological changes were examined after i.t.
of quartz with a particle diameter of not more than 7 μm
(DQ-12, Deutzche Montan Technologie, GmbH, Germany,
4 mg/rat), as a typical lung toxic agent, in F344 male rats11.
A total of 50, 10-week-old animals were separated into
two groups (Fig. 3).  Twenty-five rats were exposed to the
material suspended in saline (0.2 ml) using a specially
designed aerolizer (Penn Century, PA, USA), and subgroups
were sacrificed 1, 3, 7, 14 and 28 days thereafter.  The
remaining 25 rats were exposed by i.t. to saline (0.2 ml) as a
control group and were sacrificed on the same days.  Both
groups received intraperitoneal injections (i.p.) of 100 mg/kg
b.w. BrdU before sacrifice and underwent assessment of
lung histopathology with immunohistochemical
demonstration of BrdU, iNOS and matrix metalloproteinase-
3 (MMP-3, employed as a marker of fibrotic change).
In this experiment, after quartz treatment, lungs on Day
1 demonstrated acute inflammatory changes with neutrophil
infiltration, while granulation-like changes with giant cells
and macrophages in the alveoli were evident on Day 28.  The
results were generally in line with pronounced accumulation
of neutrophils in alveoli12.  Furthermore, the numbers of
BrdU positive cells were found to gradually decrease after
the initial peak on Day 1.  Monoclonal antibodies specific for
BrdU provide a sensitive method for detecting DNA
replication for DNA repair and cell proliferation in situ9.
The numbers and areas of iNOS positive cells, in contrast,
increased with time up to Day 28, i. e., throughout the
experimental period.  Previous studies show that iNOS is
expressed by many cells within the lung parenchyma after
exposure to various inflammatory stimuli13,14 and is also
associated with neovascularization and proliferation15.
Furthermore, iNOS activity in primary tumor tissues in cases
of fresh human gynecological and breast cancers correlates
positively with the tumor grade16,17.  Generation of oxidants
and nitric oxide, in particular, is temporally and anatomically
associated with development of lung damage, inflammation,
granulomas and fibrosis induced by inhalation of silica10.
The results suggest that Days 1 and 28 after
intratracheal instillation of fine test particles are the most
appropriate day for detection of acute and subacute
inflammatory changes, respectively.  Furthermore, BrdU on
Fig. 2. Immunohistochemical observation of BrdU and iNOS.  A, immunostaining of BrdU on Day 1; B, immunostaining of iNOS on Day 28
after i.t. of 4 mg/rat quartz.
Fig. 3. Experimental design for the sequential analysis study.  A total
of 50, 10-week-old animals were separated into two groups.
, i.t. of 4 mg/rat quartz suspended in 0.2 ml saline.   , i.t.
of 0.2 ml saline (control).  S(5), sacrifice of 5 rats.4 Bioassay of Fine Particle Toxicity
Day 1 and iNOS on Day 28 proved to be suitable end-point
markers for this purpose.
For further validation of the sequential analysis, the
toxicities of fine particles from various materials (quartz,
hydrotalcite, potassium octatitanate, palladium oxide and
carbon black) were examined using our in vivo bioassay with
a special focus on the correlations between
immunohistochemical and histopathological findings18.  A
total of 108, 10-week-old F344/DuCrj male rats were
randomly divided into 8 groups (Fig. 4).  Groups 1 to 5
underwent i.t. of the 5 test particles (4 mg/rat), quartz,
hydrotalcite, potassium octatitanate, palladium oxide and
carbon black, respectively, suspended in 0.2 ml vehicle
(saline or 10% propylene glycol and 1% sodium
carboxymethyl cellulose in saline: PG-CMC) with an
aerolizer, and subgroups of 7 rats were sacrificed on Days 1
and 28 thereafter.  Groups 6 and 7 were similarly exposed to
saline and PG-CMC, respectively, as vehicle controls, while
group 8 was maintained untreated.  Histopathological
changes and immunohistochemically assessed BrdU
labeling indices and iNOS levels were applied as end points.
From the scoring indices generated by the comparative
histopathological and immunohistochemical assessment
(Fig. 5), the quartz treated group demonstrated severe
toxicity, while the other particle treated groups all exhibited
relatively mild toxic effects.  Biochemical analyses at
different time points following instillation of different
materials earlier demonstrated that all of the exposed groups
developed granulomas.  Alveolar lipoproteinosis and
pulmonary fibrosis were most severe in the quartz treated
lungs and progressed with time19.  The present results for
BrdU immunohistochemistry demonstrated that, in all
groups, proliferation was enhanced on Day 1 due to particle
exposure but had returned to almost normal values by Day
28.  In contrast, iNOS values were higher at the latter time
point in the quartz and hydrotalcite groups.  This time course
of change in iNOS expression may be important in terms of
toxicity assessment, and it may be necessary to examine a
later time point (estimated to be about 8 months) after i.t. to
clarify the influence of change with time.  MMP-3 may
degrade cell matrix materials in areas with active
inflammation and fibrosis20.  However, in this experiment,
expression of MMP-3 was not associated with any of the
subchronic changes, such as granulation, collagenization or
fibrosis, after particle instillation.  Another marker for
fibrosis is therefore needed.
Generally, bronchoalveolar lavage (BALF) with
markers of inflammation is often used to assess the lung
toxicity of instilled test particles in rats21–23.  In our
experiment, histopathological findings and 3 different
immunohistochemical markers (BrdU, iNOS and MMP-3)
were selected and were scored in order to provide an
objective assessment.  Compared with BALF, this approach
has the advantage of allowing detailed investigation of lung
damage; it also has disadvantages, for example, in that rats
must be sacrificed at each time point and sequential changes
cannot be followed at the individual animal level.
The present study featured comparison of 5 different
particles in one experiment using an in vivo bioassay model.
There has hitherto been no data available concerning
instillation or inhalation of hydrotalcite and palladium oxide.
TISMO has been evaluated after inhalation24, and similarly,
quartz and carbon black have been evaluated after inhalation
and instillation25–28.  In this experiment, quartz exerted much
stronger toxicity than the other test particles, which did not
greatly differ in their effects.  One of the probable reasons
for this was the dose configuration.  The dose of 4 mg/rat of
quartz instilled directly into the trachea in this experiment
was selected based on data reported previously29, and dose
dependence at higher levels is currently being investigated in
Fig. 5. Scoring indices from the comparative histopathological and
immunohistochemical assessment.  The quartz-treated group
demonstrated severe toxicity, while the other hydrotalcite,
potassium octatitanate, palladium oxide and carbon black-
treated groups all exhibited relatively mild toxicity.  This
figure is modified version of that of Yokohira et al. 200716.
Fig. 4. Experimental design for validation of the sequential analysis
study.  A total of 108, 10-week-old F344/DuCrj male rats
were randomly divided into 8 groups.   , i.t. of 4 mg/rat test
substances, quartz, hydrotalcite, potassium octatitanate,
palladium oxide and carbon black, suspended in 0.2 ml saline
or PG-CMC for carbon black.   , i.t. of 0.2 ml saline or 0.2
ml PG-CMC (control).  S(7) or S(5), sacrifice of 7 or 5 rats.Yokohira, Kuno, Yamakawa et al. 5
our laboratory.
There are biologically different responses to inhalation
and instillation30, but given the rapidity with which different
particles can enter the lung, acute effects may be most
important.  The advantages of assessment of particle toxicity
using in vivo bioassays such as i.t. have been stressed23.  The
i.t. method is clearly useful for detection of acute and
subacute pulmonary particle effects using a
histopathological scoring system and markers like BrdU and
iNOS.
Dose Response Study
The dose of 4 mg quartz used by Mercer et al. (2003)29
is too large to allow for assessment of slight changes.  In fact,
the toxicities of the 5 materials in our validation experiment
were found to be only high (quartz only) or low (other
particles), with no intermediate toxicity.  In many reports of
toxicity assessment of fine particles using quartz as a
positive control, the doses employed have been less than 4
mg21,31–33.  In our study, a total of 40, 10-week-old male F344
rats were randomly separated into 4 groups of 10 rats each
(Fig. 6) and exposed by intratracheal instillation to 4 mg, 2
mg, 1 mg and 0 mg (control) quartz suspended in saline (0.2
ml) using a specially designed aerosolizer.  Subgroups of 5
rats each were sacrificed on Days 1 and 28 thereafter, and
histopathological examination was performed on the lungs.
In the quartz treated groups, granulomas were observed at 2
mg and 4 mg, with only mild inflammation was observed at
1 mg.  A dose of 4 mg does not induce any novel extra
alterations, and 1 mg is too weak to cause changes in
histopathological parameters on Day 28.  A dose of 2 mg
quartz was thus suggested to be the most appropriate dose for
sensitive detection of acute and subchronic inflammatory
changes.
Vehicle Assessment Study (Dry Powder 
Assessment)
In our experiments11,18, test particles were suspended in
saline, but this is associated with considerable agglutination.
To prevent this as much as possible, we also tested the
efficacy of a dry powder instillation method using a dry
powder insufflator without any vehicle34,35.  A total of 20,
10-week-old male F344 rats were randomly separated into 2
groups of 10 rats each (Fig. 7).  Groups 1 and 2 were exposed
to 4 mg and 0 mg (air only control) quartz powder, without
suspension in any vehicle, and 2 ml air using another type of
aerolizer, the DP-4 Insufflator (dry powder insufflator, Penn
Century, PA, USA), and sacrificed on Days 1 and 28
thereafter.  Histopathological examination revealed that 4
mg quartz dry powder also caused inflammation, but it was
mild compared with the previous experiment result with the
same dose suspended in 0.2 ml saline.  While the dry powder
instillation method may be suitable for experiments
requiring dry powder formulations, for example, to increase
stability in vaccine studies36, instillation by this method may
weaken the effects.  Because it is difficult to maintain precise
dose and it is impossible to control loss due to expiration air
after intratracheal instillation.  There are also problems in
regard to exposure of researchers since there is possibility of
aspiration.
Toxicity Assessment of a Series of Different
Particle Types
The pilot experiments suggested that a dose of 2 mg
quartz suspended in 0.2 ml saline was suggested to be most
appropriate for sensitive detection of acute and subchronic
inflammatory changes.  Using this as a control, examination
of the toxicity of a series of particles37 was performed with
our developed bioassay.  The materials chosen were 16
particles, including nanoparticles and diesel powders.  These
materials were selected to perform this validation study and
for their variety of characteristics, including shape,
composition and particle diameters with the nanometer order
or not.  Histopathological and immunohistochemical
analysis of BrdU incorporation and iNOS were performed
after exposure of the lungs.
Experiment 1: A total of 108 rats were randomly
separated into 9 groups of 12 animals in each (Fig. 8).
Groups 1–4 were exposed by i.t. to 2 mg/rat quartz, titanium
Fig. 7. Experimental design for the vehicle assessment study (dry
powder assessment).  A total of 20, 10-week-old male F344
rats were randomly separated into 2 groups of 10 rats.   , i.t.
of 4 mg/rat quartz powder with 0.2 ml air using a DP-4
Insufflator (dry powder insufflator).   , i.t. of 2 ml air
(control).  S(5), sacrifice of 5 rats.
Fig. 6. Experimental design for the dose response study.  A total of
40, 10-week-old male F344 rats were randomly separated into
4 groups of 10 rats.   , i.t. of 4 mg, 2 mg or 1 mg/rat quartz
suspended in 0.2 ml saline.   , i.t. of 0.2 ml saline (control).
S(5), sacrifice of 5 rats.6 Bioassay of Fine Particle Toxicity
dioxide, hydrotalcite and β-cyclodextrin suspended in 0.2 ml
saline, and Groups 5 and 6 were exposed by i.t. to 2 mg/rat
K2PdCl4 and Na2PdCl4 suspended in 0.2 ml distilled water.
Distilled water was employed as a vehicle because only the
bases, Na and K, of K2PdCl4 and Na2PdCl4 differed.  Groups
7–9 were maintained as controls (saline, distilled water or
untreated).  Subgroups of 6 rats were sacrificed on Days 1
and 28.
Experiment 2: A total of 106 rats were randomly
separated into 9 groups (12 rats each in Group 1–8, 10 rats in
Group 9).  Groups 1–7 were exposed by i.t. to 2 mg/rat
quartz, titanium dioxide, CuO, CuO nano, MnO2, NiO and
NiO nano suspended in 0.2 ml saline, and Groups 8 and 9
were maintained as controls (saline or untreated).
Subgroups of 6 rats were sacrificed on Days 1 and 28.
Experiment 3: A total of 96 rats were randomly
separated into 8 groups of 12 rats each.  Groups 1–4 and 6
were exposed by i.t. to 2 mg/rat quartz, diesel standard
powder, diesel powder, C6H10O4Pd and CaCO3 suspended in
0.2 ml saline, and Group 5 was exposed to neutralized
Na2PdCl4 (final pH was 6.5) in 20 mM phosphate buffer and
5 N NaCl.  Groups 7 and 8 were maintained as vehicle
controls (saline or vehicle of Group 5).  Subgroups of 6 rats
were sacrificed on Days 1 and 28.
In order to assess toxicity to lungs for each fine particle
material and to screen for hazard in a relatively simple way,
toxicity points for each particle or chemical were calculated
from histopathological and the immunohistochemical BrdU
and iNOS findings (Table 1) and placed in order.  More
detailed information on total toxicity points has previously
been reported by Yokohira et al.37.  The results of the
evaluation of particle toxicity by total toxicity points are
outlined below, and summarized results for fine particle
toxicity are detailed in Fig. 9.  Only CuO caused greater
toxicity than quartz; the other particles had relatively minor
effects.  Although some materials, including nanoparticles,
demonstrated toxicity that was too strong for sensitive
assessment, the ranking order could be clarified as follows:
CuO > quartz > neutralized Na2PdCl4 > NiO > hydrotalcite
> MnO2 > diesel > titanium dioxide (in Experiment 2) > β-
cyclodextrin > diesel standard > titanium dioxide (in
Experiment 1) > CaCO3.
The various particles employed in the present study,
quartz, titanium dioxide, hydrotalcite and β-cyclodextrin,
K2PdCl4, Na2PdCl4, CuO, CuO nano, MnO2, NiO, NiO
nano, diesel standard powder, diesel powder, C6H10O4Pd
and CaCO3, were chosen based on likelihood of human
exposure.  Hydrotalcite is employed as an antacid, and β-
cyclodextrin is employed as a food additive and in the
pharmaceutical field to improve dissolution, chemical
stability and bioavailability37–39.  CaCO3 is calcium
carbonate, is commonly referred to as chalk40, and in
industrial plants, workers may breathe in K2PdCl4
41,
Na2PdCl4
42, C6H10O4Pd (the preceding 3 particles are used
as catalysers), CuO, CuO nanoparticles, MnO2, NiO or NiO
nanoparticles.  Diesel powder is a problematic air pollutant
capable of inducing inflammation43.
All rats instilled with K2PdCl4 or Na2PdCl4 solution
died from severe hemorrhage and edema of the lungs
following intratracheal instillation in Experiment A.  The pH
values of the K2PdCl4 and Na2PdCl4 solutions were strongly
acidic at 3.2, and this presumably was a major contributor to
Fig. 8. Experimental design for the toxicity assessment of a series of
different particle types (Experiments 1–3).  [Experiment 1]
, i.t. of 2 mg/rat quartz, titanium dioxide, hydrotalcite or β-
cyclodextrin suspended in 0.2 ml saline or K2PdCl4 and
Na2PdCl4, suspended in 0.2 ml distilled water.   , i.t. of 0.2
ml saline or distilled water (control).  S(6), sacrifice of 6 rats.
[Experiment 2]  , i.t. of 2 mg/rat test substances, quartz,
titanium dioxide, CuO, CuO nanoparticles, MnO2, NiO or
NiO nanoparticles suspended in 0.2 ml saline.   , i.t. of 0.2
ml saline (control).  S(6), sacrifice of 6 rats.  [Experiment 3]
, i.t. of 2 mg/rat quartz, diesel standard powder, diesel
powder, C6H10O4Pd or CaCO3 suspended in 0.2 ml saline or
neutralized Na2PdCl4 (final pH was 6.5) in 20 mM phosphate
buffer and 5 N NaCl.   , i.t. of 0.2 ml saline or vehicle of
Na2PdCl4 (control).  S(6), sacrifice of 6 rats.
Fig. 9. Results for the fine particle toxicity.  *, indicates the
experiment number (Experiment 1, 2 or 3).  Some materials,
including nanoparticles, demonstrated toxicity that was too
strong for sensitive assessment.  The ranking order is CuO >
quartz > neutralized Na2PdCl4 > NiO > hydrotalcite > MnO2 >
diesel > titanium dioxide (in Experiment 2) > β-cyclodextrin
> diesel standard > titanium dioxide (in Experiment 1) >
CaCO3.  This figure is modified version of that of Yokohira et
al. 200835.Yokohira, Kuno, Yamakawa et al. 7
lung damage.  The lungs instilled with neutralized Na2PdCl4
also demonstrated severe inflammatory changes on Day 1.
The findings for lungs treated with C6H10O4Pd were almost
the same, severe hemorrhage and edema, as those for
K2PdCl4 and Na2PdCl4.  However, the pH value of the
C6H10O4Pd solution was 4.9, which was not sufficiently
acidic to lead to death.  Schmid et al. reported that PdSO4
exerts significant effects on human epithelial lung cells44,
and we have previously confirmed PdO toxicity in rats18.
Based on the available results, it is possible that not only
strong acids but also palladium itself has toxic potential in
the lung.
In the case of CuO and NiO, the diameters of the
particles were in the micrometer and nanometer ranges.
With the same volume of material, the nanoparticles of both
CuO and NiO caused much more severe acute toxicity.  In
general, it is likely that nanoparticles exert a greater impact
because of the area and characteristics of the surfaces45.
Furthermore, effects may be exerted in secondary sites.  For
example, an oral administration study in mice indicated that
titanium dioxide is retained in the liver, spleen, kidney and
lung tissues after uptake through the gastrointestinal tract46.
However, no remarkable histopathological changes were
seen in the liver and kidneys after treatment with
nanoparticles of CuO or NiO in the present study.  Also, NiO
nanoparticles induced only mild inflammatory change in the
lungs on Day 1.  Toya et al. similarly found limited
histopathological effects on the lungs with 13.0 mg NiO
powder/kg b.w.47.  Further examination is necessary to
clarify the causes of death observed here.
To establish a bioassay model for detection of lung
toxicity due to fine particles for screening purposes, both
positive and negative controls are needed.  Quartz is known
as a typical lung toxic agent48 and provides a reliable positive
control.  Titanium dioxide was classified as belonging to
Group 2B (possibly carcinogenic to humans) in a recent
International Agency for Research on Cancer (IARC)
publication49, but Hext et al. concluded from an overview of
epidemiology studies and toxicology studies in mice, rats
and hamsters that titanium dioxide dust should not exert
carcinogenic effects in the human lung50.  On the other hand,
titanium dioxide has carcinogenic potential51, and exposure
may result in formation of DNA adducts52.  With earlier
assessment of acute or subacute findings, the severity of
toxicity differed according to the instilled particles: quartz >
80:20 anatase:rutile and ultrafine titanium dioxide > fine-
sized rutile titanium dioxide = ultrafine rutile titanium
dioxide53,54.  Use of titanium dioxide as a negative control
should be considered, where possible, for experimental
purposes.  In both Experiments 1 and 2, titanium dioxide was
employed as a negative control.  However, the respective
total toxicity points were 3.0 and 8.9.  A total point value of
8.9 seems excessively high for a negative control.  However,
based on the total points in these experiments, at least 3
rough grades of toxicity level, severe, moderate and mild,
could be determined.  It is expected that further
investigations to obtain more particle toxicity data will allow
more sensitive assessment of the toxicity of particles in the
future.
Table 1. Toxicity Points for Evaluation of Particle Toxicity (Experiments A–C)
No. of Histopathologya Inmmunohistochemistryb
Toxicity
Chemicals rats BrdU iNOS points
Experiment 1 Quartz 12 10.0 10.0 10.0 30.0
Titanium dioxide 12 2.8 –0.1 0.4 3.0
Hydrotalcite 12 3.3 6.3 1.9 11.5
β-cyclodextrin 12 1.8 3.5 0.1 5.4
Experiment 2 Quartz 12 10.0 10.0 10.0 30.0
Titanium dioxide 12 3.5 3.0 2.4 8.9
CuO 12 11.6 18.1 7.5 37.2
CuO nano 0 –c –– –
MnO2 12 4.2 0.8 5.1 10.1
NiO 10 7.1 2.9 4.7 14.7
NiO nano 0 – – – –
Experiment 3 Quartz 12 10.0 10.0 10.0 30.0
Diesel standard 12 2.1 1.6 1.2 4.9
Diesel 12 1.9 5.0 2.2 9.1
C6H10O4Pd 0 – – – –
Neutralized Na2PdCl4 12 4.2 20.3 3.3 27.8
CaCO3 12 1.0 1.0 0.4 2.4
a Points are relative to 10 points (full marks) for quartz derived from the histopathological scoring indices.
b Total points for imunohistopathological changes of BrdU and iNOS derived from labeling indices.
c No data due to mortality.
Based on modified from Yokohira et al. 200835.8 Bioassay of Fine Particle Toxicity
Conclusion
The results of several pilot experiments, performed in
rats using quartz as a typical lung toxic particle, suggest that
Days 1 and 28 after i.t. of 2 mg of fine test particles
suspended in 0.2 ml vehicle are the most appropriate for
detection of acute and subacute inflammatory changes,
respectively.  Furthermore, BrdU on Day 1 and iNOS on Day
28 proved to be suitable end-point markers for this purpose.
Examination of the toxicity of a series of particles could be
performed with the developed bioassay55.  Although some
materials, including nanoparticles, demonstrated toxicity
that was too strong for sensitive assessment, a ranking order
could be clarified.
Our bioassay does suffer from a weakness in that even
low doses of some particles may lead to death.  Further dose
range studies are necessary.  The i.t. method has been
proposed as the most reliable route for assessing the
pulmonary toxicity of particles in rodents56, although there
are biologically different responses to inhalation and
instillation30.
Another limitation of this bioassay is that the toxicity of
particles can only be detected at an early stage because the
experimental period is limited to 28 days.  In this
experiment, a dose response study was performed for quartz,
not for risk assessment, but for improvement of the bioassay,
and this study was not performed with other test particles.
For risk assessment, more experiments, including dose
response studies for each test particle with hazard
characterization, should be conducted.  With in that said, the
bioassay was originally designed to be used for hazard
identification at an early stage and to rank the toxicities of
various particles given at single representative
concentrations.  The approach adopted clearly is also useful
for detection of acute and subacute pulmonary particle
characteristics using a histopathological scoring system and
markers like BrdU and iNOS for screening purposes.
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